Compare Nuwellis Inc (NUWE) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Sirius XM Holdings Inc — how do they compare? Nuwellis Inc trades at $0.7 (market cap $2.20M), while Sirius XM Holdings Inc trades at $27.05 (market cap $8.87B). The key difference: Sirius XM Holdings Inc is far larger — about 4031.8× Nuwellis Inc's market cap, and Sirius XM Holdings Inc pays a 4.1% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Sirius XM Holdings Inc for 102 Days on average.
| NUWE | SIRI | |
|---|---|---|
Market Cap | $2.20M | $8.87B |
Volume | 121,544 | 4,324,672 |
Sector | Health | Media |
52-Week High | $146.65 | $32.59 |
52-Week Low | $0.68 | $19.92 |
Typical Hold Time | 26 Days | 102 Days |
Enterprise Value | -$1.52M | $18.16B |
Dividend Yield | — | 4.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
SIRI trades at $25.95, down 1.56% with a bearish technical signal. The company shows mixed fundamentals with a P/E of 10.57 and P/B of 0.75 indicating potential undervaluation, but recent earnings misses and a significant net loss in 2024 raise concerns. Positive cash flow growth and a 62.5% analyst buy rating provide support, while the YouTube partnership offers growth potential.
The stock presents a value opportunity with upside to the $34.43 consensus target, but faces execution risks from subscription pressure and high debt. Recent institutional buying and management's focus on cash flow growth are positive catalysts, though technical weakness and competitive threats warrant caution for near-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
